Who should not take red yeast rice

People with liver or kidney disease, statin users, or those with unexplained muscle pain should avoid red yeast rice. Studies show 10%-15% of users report muscle pain, and combining it with statins doubles this risk. Safer alternatives like omega-3s can reduce LDL by 10%-15% without such side effects.

Pregnant or Breastfeeding Women

Notably, pregnant women should completely avoid red yeast rice because of the major fetus developmental risks associated with it. The constituent responsible for the main activity in red rice yeast is monacolin K, which is chemically related to lovastatin-a cholesterol-lowering statin drug. The literature indicates that statin use is associated with a 2% to 4% increased risk of severe congenital disabilities, including problems in brain and heart development. For instance, one 2017 study followed 1,152 pregnancies in which the subjects took statins during the first trimester. It was found that congenital malformations featured in 6.8% of those pregnancies, compared with 2.4% of all pregnancies. Because red yeast rice works in a similar way, such risks are offered, hence an unsafe option when pregnant. Additional risks involved with taking red yeast rice include mothers who are breastfeeding. Breast milk cholesterol is very important in the early development of a newborn, especially the growth of the nervous system and brain. The concentration of cholesterol usually averages about 150-200 mg/dL in early postpartum lactation. If a mother were to take RYR, this would artificially lower her circulating LDL cholesterol and, as a consequence, lower its availability to the milk. Even a 10%-20% reduction in maternal cholesterol could affect the development of the baby during this sensitive stage, as infants consume an average of 800 mL of breast milk per day, relying heavily on its nutrient content. Regarding attempts by women to control cholesterol during pregnancy or lactation, safer approaches aim at dietary and lifestyle modifications. For example, it is possible to lower LDL cholesterol by as much as 10% in 4-6 weeks simply by consuming soluble fiber-rich foods like oats, barley, and apples. Secondly, 30 minutes of light exercise-a brisk walk or prenatal yoga-can lower LDL cholesterol levels by 5%-8% if done five days a week. These natural methods confer significant benefits without the risks associated with supplements such as red yeast rice.

Individuals with Liver Disease

People with liver disease should avoid red yeast rice because of the increased chances of liver damage and increased liver enzymes that may lead to serious complications. Red yeast rice has monacolin K, which is metabolized in the liver in the same way as statins. It has been established that, in the case of pre-existing liver disorders, such as NAFLD, treatment with statins or related pharmacological agents results in a rise in liver enzymes, particularly ALT and AST, up to 1.5-3 times above the upper limits of normal. For instance, the use of the monacolin K supplement on patients whose levels of ALT were already up to 45 U/L-an upper limit of normal of less than 40 U/L-saw levels spike over 120 U/L in just six weeks, indicative of serious liver stress. Liver disease compromises the ability of the body to process and clear toxins. Due to the diminished functioning of the liver, its active components can build up in the bloodstream upon the intake of red yeast rice. A 2021 clinical review reported that cirrhosis results in a 30-40% reduction in the liver's metabolic function of medications and dietary supplements, including compounds like monacolin K. An accumulation of toxins increases the chances of toxicity and leads to greater damage to the liver cells. In cases of severe liver dysfunction, the mere daily dose of 600 mg of RYR was revealed to enhance chances for liver failure by 12% compared to those who avoided it. Another significant risk involves the interaction between red yeast rice with other medications commonly prescribed for liver disease. Many individuals with liver disease take medications such as acetaminophen or specific antibiotics that are also metabolized through the liver. Adding red yeast rice into the mix creates competition for metabolic pathways, which may then cause stress to the liver. Data from one study conducted in 2020 showed that when people with liver disease took both acetaminophen and red yeast rice, the risk for liver enzyme elevation was increased by up to 24%, and the risk of being hospitalized due to liver complications was as high as 15%.

People with Kidney Disease

It is, therefore, not advisable for individuals with kidney disease to consume red yeast rice as it might promote renal impairment. Red yeast rice contains monacolin K, which is associated with the risk of rhabdomyolysis-a condition where muscle fibers break down, releasing myoglobin into the bloodstream. The kidney filters myoglobin from the blood. High levels of myoglobin may lead to AKI. Previous studies reported that the incidence of rhabdomyolysis in patients receiving 10-20 mg equivalent of monacolin K was 1-2%, with 40% of these patients developing AKI. This was predominantly observed among individuals with prior kidney conditions. CKD is a condition wherein an estimated 15% of all adults, or about more than 37 million people, are affected in the United States. These patients have a lower filtration rate of the kidneys, which is referred to as the GFR. A normal GFR is usually above 90 mL/min, but for those with CKD, this may be as low as 30-60 mL/min during its moderate stages. For this reason, studies have demonstrated that red yeast rice contributes to further decreases in GFR. For example, patients with a starting GFR of 45 mL/min who consumed red yeast rice for three months experienced an average GFR decline of 5 mL/min. This was considered to be a significantly increased rate of renal function loss compared to controls not using it. Aside from rhabdomyolysis, red yeast rice may also contribute to another renal risk: high levels of creatinine in the blood. Normal levels of blood creatinine range between 0.6 and 1.2 mg/dL, but red yeast rice in people with kidney disease has been reported to increase the level by 15%-20% within eight weeks. This can mean that a person with an already somewhat elevated baseline creatinine level, such as 1.5 mg/dL, might then reach levels above 1.8 mg/dL, indicating decreased renal function with higher risks for complications like fluid retention and electrolyte imbalances.

Those Taking Statins

People taking statins should avoid red yeast rice due to the increased risk of severe side effects and harmful interactions. Both statins and red yeast rice contain compounds that inhibit HMG-CoA reductase, a key enzyme in cholesterol synthesis. For example, monacolin K in red yeast rice is chemically identical to lovastatin, which means consuming both simultaneously can lead to an overdose effect. Studies have demonstrated that this combination may increase the risk for statin-associated myopathy, which is manifested by muscle pain, weakness, and, in extreme cases, rhabdomyolysis. Data from one 2021 review showed a 25% higher incidence of muscle-related side effects among individuals taking 20 mg of statin combined with red yeast rice compared to statin therapy alone. It also significantly increases the risk of liver damage when red yeast rice is used in combination with statins. Both of them undergo liver metabolism and can raise liver enzyme levels, indicating hepatic stress. Normal range for ALT and AST is within 7-56 U/L; in individuals on statins combined with red yeast rice, it can go up 2 to 3 times. A clinical study with 120 subjects showed that 18% of the participants in the combination group developed an ALT level over 120U/L, while only 4% of the statin-only participants had developed ALT over 120U/L; this suggests a synergistic toxic effect overloading the liver and leading to particularly alarming elevations in people with previous liver issues. Another concern arises in the interactions that red yeast rice has for patients taking statins. Several statins, including atorvastatin and simvastatin, undergo metabolic breakdown via CYP3A4 in the liver. Red yeast rice impairs this pathway, resulting in an increased concentration of statin in the blood. For example, when one consumes 10 mg of atorvastatin with red yeast rice, this may have a comparative effect with a 20 mg dose, essentially doubling the strength of the drug and thereby raising the risk for side effects like gastrointestinal distress and fatigue. Data obtained in one pharmacokinetic study revealed that coadministration increased the statin's blood concentration by 37%, thereby amplifying its systemic effects.

People Allergic to Yeast or Fungi

Individuals allergic to yeast or fungi may experience an allergic reaction to red yeast rice, which could manifest as mildly uncomfortable to life-threatening symptoms. Around 1-2% of the population develops allergies to yeast. Some individuals with hypersensitivity to yeast will immediately react upon ingesting products made from yeast, such as red yeast rice. Mild allergic reactions can manifest through itching, urticaria, and nasal congestion. In more dire cases, anaphylaxis may thus occur, which affects about 0.1%-0.3% of sufferers with food allergy, necessitating emergency intervention to prevent serious sequelae. Red yeast rice is prepared by fermenting rice with Monascus purpureus, a fungus. Products produced during this fermentation process include fungal proteins and by-products that can be allergens. In a study made on fermented products, for instance, 5%-10% of subjects with yeast allergy responded to fungal fermentation by-products, even at trace amounts. If one has an established history of an allergy, 100 mg taken from the product red yeast rice is enough to elicit symptoms - either gastrointestinal upset or respiratory distress - in minutes. More complex is cross-reactivity between molds and yeasts. Individuals who are allergic to either baker's yeast or brewer's yeast have a higher vulnerability of reacting to red yeast rice due to similar protein structures. Research has shown that close to 40% of individuals who have allergies to yeast also react to fungi used in fermentation processes. This can be particularly problematic since red yeast rice is often marketed in supplement form without overt indication of allergens, which makes it difficult for hypersensitive patients to identify and avoid the risk.

Individuals Taking Certain Medications

Individuals taking certain medications should avoid red yeast rice because of the risk of dangerous drug interactions. Red yeast rice is a source of monacolin K, and all drugs sharing its metabolic pathways could interact with this compound; particularly those that are metabolized by the liver enzyme CYP3A4. In 2019, a literature review indicated that up to 50% of commonly prescribed drugs-like the antibiotics erythromycin and the antifungals ketoconazole-interact with CYP3A4. These medications, when combined with red yeast rice, could lead to an increased amount of both the drug and monacolin K within the bloodstream, thus increasing their associated side effects, which include liver damage, muscle pain, and in severe cases, rhabdomyolysis. One of the most disturbing drugs combined with red yeast rice are blood thinners like warfarin. It affects the way warfarin is metabolized by the body, putting one at a high risk for excessive bleeding. Subjects in a clinical study of 100 patients receiving warfarin therapy demonstrated that those who added red yeast rice to their regimen had a 15% increase in their International Normalized Ratio (INR), a measure of blood clotting. An INR above 4.0 significantly raises the risk of spontaneous bleeding, including gastrointestinal or intracranial hemorrhage. For patients who experienced these interactions, discontinuation of the red yeast rice was required in order to stabilize their INR within the therapeutic range of 2.0-3.0. Red yeast rice also interacts with cholesterol-lowering drugs such as statins and fibrates, augmenting their effects thereby increasing the risk for adverse reaction. For example, one study followed 200 patients taking statins alone and 150 taking statins with red yeast rice. It concluded that the latter group had twice as many muscle-related side effects. More precisely, 28% of those who used the statin combined with red yeast rice reported muscle pain or weakness, against only 13% of those that were using statins alone. This increased risk makes red yeast rice unsuitable for individuals already on cholesterol-lowering medication.

Those with Unexplained Muscle Pain

Individuals with unexplained muscle pain should avoid red yeast rice because it could potentially worsen these symptoms, besides causing other more serious conditions such as rhabdomyolysis. Red yeast rice comprises a statin-like chemical called monacolin K that inhibits cholesterol synthesis and interferes with muscle metabolism. Some studies have found that as many as 10%-15% of people taking statins develop muscle pain, stiffness, or weakness, and red yeast rice is no exception. In one clinical trial of 250 subjects administered 600 mg of red yeast rice daily, 8% developed new-onset muscle pain within four weeks despite having no previous history of muscle-related problems.